Practical Guidance on How to Handle Levodopa/Carbidopa Intestinal Gel Therapy of Advanced PD in a Movement Disorder Clinic

Continuous dopaminergic delivery is recognized for the capacity to ameliorate symptoms in Parkinson’s disease (PD). In advanced PD the short comings of orally administered Levodopa/Carbidopa include fluctuations resulting in unstable effect and dyskinesia. Levodopa/Carbidopa intestinal gel, LCIG, (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Stephen Wørlich, Clausen, Jesper, Gregerslund, Mie Manon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406266/
https://www.ncbi.nlm.nih.gov/pubmed/22848335
http://dx.doi.org/10.2174/1874205X01206010037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406266/
https://www.ncbi.nlm.nih.gov/pubmed/22848335
http://dx.doi.org/10.2174/1874205X01206010037

Ejemplares similares